Research Studies » Multiple Sclerosis |
Patients who, as part of their routine clinical care and according to the locally approved label, are either: • Starting fingolimod at time of study entry; • Starting another approved DMT or started prior to study entry (within maximum 6 months); and • Willing to provide written informed consent (patient or legal representative). |